508 related articles for article (PubMed ID: 17900565)
1. Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells.
Li H; Zhou J; Miki J; Furusato B; Gu Y; Srivastava S; McLeod DG; Vogel JC; Rhim JS
Exp Cell Res; 2008 Jan; 314(1):92-102. PubMed ID: 17900565
[TBL] [Abstract][Full Text] [Related]
2. A telomerase-immortalized primary human prostate cancer clonal cell line with neoplastic phenotypes.
Gu Y; Kim KH; Ko D; Nakamura K; Yasunaga Y; Moul JW; Srivastava S; Arnstein P; Rhim JS
Int J Oncol; 2004 Oct; 25(4):1057-64. PubMed ID: 15375556
[TBL] [Abstract][Full Text] [Related]
3. A novel neoplastic primary tumor-derived human prostate epithelial cell line.
Ko D; Gu Y; Yasunaga Y; Nakamura K; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Arnstein P; Taylor DO; Hukku B; Rhim JS
Int J Oncol; 2003 Jun; 22(6):1311-7. PubMed ID: 12738999
[TBL] [Abstract][Full Text] [Related]
4. A novel human cancer culture model for the study of prostate cancer.
Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
[TBL] [Abstract][Full Text] [Related]
5. Isolation of epithelial stem cells from dermis by a three-dimensional culture system.
Medina RJ; Kataoka K; Takaishi M; Miyazaki M; Huh NH
J Cell Biochem; 2006 May; 98(1):174-84. PubMed ID: 16408300
[TBL] [Abstract][Full Text] [Related]
6. Stem/progenitor and intermediate cell types and the origin of human prostate cancer.
Tokar EJ; Ancrile BB; Cunha GR; Webber MM
Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of human gastric cell lines with stem cell phenotypes.
Yang YC; Wang SW; Hung HY; Chang CC; Wu IC; Huang YL; Lin TM; Tsai JL; Chen A; Kuo FC; Wang WM; Wu DC
J Gastroenterol Hepatol; 2007 Sep; 22(9):1460-8. PubMed ID: 17645461
[TBL] [Abstract][Full Text] [Related]
8. Potential of progenitors from postnatal cerebellar neuroepithelium and white matter: lineage specified vs. multipotent fate.
Milosevic A; Goldman JE
Mol Cell Neurosci; 2004 Jun; 26(2):342-53. PubMed ID: 15207858
[TBL] [Abstract][Full Text] [Related]
9. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
Templin C; Kotlarz D; Rathinam C; Rudolph C; Schätzlein S; Ramireddy K; Rudolph KL; Schlegelberger B; Klein C; Drexler H
Exp Hematol; 2008 Feb; 36(2):204-15. PubMed ID: 18206728
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
Gu Y; Li H; Miki J; Kim KH; Furusato B; Sesterhenn IA; Chu WS; McLeod DG; Srivastava S; Ewing CM; Isaacs WB; Rhim JS
Exp Cell Res; 2006 Apr; 312(6):831-43. PubMed ID: 16413016
[TBL] [Abstract][Full Text] [Related]
11. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
13. Generation of multipotent cell lines from a distinct population of male germ line stem cells.
Izadyar F; Pau F; Marh J; Slepko N; Wang T; Gonzalez R; Ramos T; Howerton K; Sayre C; Silva F
Reproduction; 2008 Jun; 135(6):771-84. PubMed ID: 18502893
[TBL] [Abstract][Full Text] [Related]
14. hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.
Kogan I; Goldfinger N; Milyavsky M; Cohen M; Shats I; Dobler G; Klocker H; Wasylyk B; Voller M; Aalders T; Schalken JA; Oren M; Rotter V
Cancer Res; 2006 Apr; 66(7):3531-40. PubMed ID: 16585177
[TBL] [Abstract][Full Text] [Related]
15. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells.
Matulka LA; Triplett AA; Wagner KU
Dev Biol; 2007 Mar; 303(1):29-44. PubMed ID: 17222404
[TBL] [Abstract][Full Text] [Related]
16. Identification of nestin-positive putative mammary stem cells in human breastmilk.
Cregan MD; Fan Y; Appelbee A; Brown ML; Klopcic B; Koppen J; Mitoulas LR; Piper KM; Choolani MA; Chong YS; Hartmann PE
Cell Tissue Res; 2007 Jul; 329(1):129-36. PubMed ID: 17440749
[TBL] [Abstract][Full Text] [Related]
17. Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells.
Bhatia B; Tang S; Yang P; Doll A; Aumüeller G; Newman RA; Tang DG
Oncogene; 2005 May; 24(22):3583-95. PubMed ID: 15750631
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the neurogenic potential of multipotent skin-derived precursors.
Fernandes KJ; Kobayashi NR; Gallagher CJ; Barnabé-Heider F; Aumont A; Kaplan DR; Miller FD
Exp Neurol; 2006 Sep; 201(1):32-48. PubMed ID: 16678161
[TBL] [Abstract][Full Text] [Related]
19. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic transformation by TERT in FGF-2-expanded human mesenchymal stem cells.
Yamaoka E; Hiyama E; Sotomaru Y; Onitake Y; Fukuba I; Sudo T; Sueda T; Hiyama K
Int J Oncol; 2011 Jul; 39(1):5-11. PubMed ID: 21573488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]